Clinical use of non-invasive diagnostic biomarkers for antibody-mediated rejection and integration in the risk assessment pipeline for renal transplantation management. KU Leuven
Compared to dialysis, kidney transplantation remains the optimal treatment option with better patient outcomes, higher quality of life and lower costs. However, barriers to the success of transplantation remain. A major hurdle is the significant loss of allograft function over time after transplantation.
A thorough understanding of the causes of graft failure is the first step towards improving outcomes. However, few contemporary ...